Clinical Trial Update: Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase I study of CDX-1307, an hCG-B vaccine, in patients with incurable locally advanced or metastatic breast, colorectal, pancreatic, bladder, or ovarian cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Ovarian Cancer
• Pancreatic Cancer

Drugs mentioned

• CDX-1307 (hCG-B vaccine)

Snippet

Sponsor: Celldex Therapeutics | Conditions: Breast Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED